Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase
The increase in antibiotic resistance among Gram-positive bacteria underscores the urgent need to develop new antibiotics. New antibiotics should target actively growing susceptible bacteria that are resistant to clinically accepted antibiotics including bacteria that are not growing or are protecte...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/17c1c0e3cb234f2b884059fda98a0fcd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:17c1c0e3cb234f2b884059fda98a0fcd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:17c1c0e3cb234f2b884059fda98a0fcd2021-11-25T18:40:00ZTwo Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase10.3390/ph141111821424-8247https://doaj.org/article/17c1c0e3cb234f2b884059fda98a0fcd2021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1182https://doaj.org/toc/1424-8247The increase in antibiotic resistance among Gram-positive bacteria underscores the urgent need to develop new antibiotics. New antibiotics should target actively growing susceptible bacteria that are resistant to clinically accepted antibiotics including bacteria that are not growing or are protected in a biofilm environment. In this paper, we compare the in vitro activities of two new semisynthetic glycopeptide antibiotics, MA79 and ERJ390, with two clinically used glycopeptide antibiotics—vancomycin and teicoplanin. The new antibiotics effectively killed not only exponentially growing cells of <i>Staphylococcus aureus</i>, but also cells in the stationary growth phase and biofilm.Vladimir VimbergLeona ZieglerovaAninda MazumdarZsolt SzűcsAniko BorbásPál HerczeghGabriela Balikova NovotnaMDPI AGarticleantibiotic resistanceglycopeptide antibiotics<i>Staphylococcus aureus</i>teicoplanin pseudoaglyconMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1182, p 1182 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
antibiotic resistance glycopeptide antibiotics <i>Staphylococcus aureus</i> teicoplanin pseudoaglycon Medicine R Pharmacy and materia medica RS1-441 |
spellingShingle |
antibiotic resistance glycopeptide antibiotics <i>Staphylococcus aureus</i> teicoplanin pseudoaglycon Medicine R Pharmacy and materia medica RS1-441 Vladimir Vimberg Leona Zieglerova Aninda Mazumdar Zsolt Szűcs Aniko Borbás Pál Herczegh Gabriela Balikova Novotna Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase |
description |
The increase in antibiotic resistance among Gram-positive bacteria underscores the urgent need to develop new antibiotics. New antibiotics should target actively growing susceptible bacteria that are resistant to clinically accepted antibiotics including bacteria that are not growing or are protected in a biofilm environment. In this paper, we compare the in vitro activities of two new semisynthetic glycopeptide antibiotics, MA79 and ERJ390, with two clinically used glycopeptide antibiotics—vancomycin and teicoplanin. The new antibiotics effectively killed not only exponentially growing cells of <i>Staphylococcus aureus</i>, but also cells in the stationary growth phase and biofilm. |
format |
article |
author |
Vladimir Vimberg Leona Zieglerova Aninda Mazumdar Zsolt Szűcs Aniko Borbás Pál Herczegh Gabriela Balikova Novotna |
author_facet |
Vladimir Vimberg Leona Zieglerova Aninda Mazumdar Zsolt Szűcs Aniko Borbás Pál Herczegh Gabriela Balikova Novotna |
author_sort |
Vladimir Vimberg |
title |
Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase |
title_short |
Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase |
title_full |
Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase |
title_fullStr |
Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase |
title_full_unstemmed |
Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase |
title_sort |
two novel semisynthetic lipoglycopeptides active against <i>staphylococcus aureus</i> biofilms and cells in late stationary growth phase |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/17c1c0e3cb234f2b884059fda98a0fcd |
work_keys_str_mv |
AT vladimirvimberg twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase AT leonazieglerova twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase AT anindamazumdar twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase AT zsoltszucs twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase AT anikoborbas twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase AT palherczegh twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase AT gabrielabalikovanovotna twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase |
_version_ |
1718410818502000640 |